Clin2
NCT07346690Possibly a fitNot yet recruiting

Study of THC doses on mind and body

Evaluate PK ProfileEvaluate PD ProfileHealthy AdultsSafety and Tolerability in Healthy Volunteers

Treatments studied

Part of Mental health clinical trials.

This trial tests how different amounts of THC (the active part of cannabis) affect your thinking and body functions. It may help researchers understand safe and effective dosing.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
24 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You do not have any major medical or mental health conditions.
  • You have used cannabis at least once before and tolerated it well.
  • You are not pregnant or breastfeeding.
  • You do not have a close family member with bipolar disorder, psychosis, or schizophrenia.
  • You have never had a bad reaction or allergy to cannabis and you do not use recreational drugs currently.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05432284Not yet recruiting· Phase 1
Testing THC and myrcene effects on the brain and behavior

This Phase 1 study tests how inhaled THC and a natural plant chemical called myrcene affect behavior, thinking, and safety in healthy adults. You may help researchers understand potential brain/behavior effects before larger studies.

Baltimore, Maryland
NCT02811510Recruiting· Phase 1
Study of THC effects on people with past cannabis use

This Phase 1 study tests how THC (the main active ingredient in cannabis) affects healthy adults, and whether effects differ by gender. It’s designed to learn about short-term body and brain responses to THC.

West Haven, Connecticut
NCT02781519Recruiting· Phase 1
Study how THC affects men and women who have used cannabis before

This Phase 1 study tests how delta-9 THC (the main active ingredient in cannabis) affects healthy adults, and whether the effects differ by gender. It may help researchers understand risks and responses to THC, which could guide safer use and future treatments.

West Haven, Connecticut
NCT07105449Recruiting
Testing high-potency cannabis concentrates in regular users

This study looks at how high-potency cannabis concentrates affect people who already use cannabis a few times a week. You will be asked to vape a concentrate and then have your reactions monitored.

Toronto, Ontario
NCT06948136Recruiting· Phase 1
THC effects in older adults trial

This trial studies how a single dose of THC (the active ingredient in cannabis) affects older adults. It aims to understand the effects in this age group, which may help guide safe use.

West Haven, Connecticut
NCT06758596Not yet recruiting· Early Phase 1
Cannabis and brain function in young adults

This study looks at how a cannabis extract affects brain activity in healthy young adults who use cannabis occasionally. It uses brain scans to understand changes and may help guide future treatments.

Chicago, Illinois

Hear when a new Safety and Tolerability in Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.